P4‐016: MCLENA‐1: A PHASE II CLINICAL TRIAL FOR THE ASSESSMENT OF SAFETY, TOLERABILITY, AND EFFICACY OF LENALIDOMIDE IN PATIENTS WITH MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER'S DISEASE; TRIAL DESIGN AND RATIONALE. (1st July 2019) - Decourt, Boris; Fulkerson, Nadia; Burns, Alana; Lee, Garam; St Rose, Tessa; Hartley, Katurah; Dardis, Christopher; Wilson, Jeffrey; Sabbagh, Marwan N.